Arthur D. Little Study Establishes Precise Impact of AI on Development and Engineering and Outlines Concrete Actions to Drive Success
19.2.2025 10:00:00 CET | Business Wire | Press release
Harnessing AI will transform development and engineering functions – but success requires organizations to reshape themselves. That is one of key findings of a major Arthur D. Little (ADL) report, which highlights how AI can contribute to 25% growth and 60% productivity gains by 2030 across the innovation cycle, and provides concrete actions for companies to take now.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250219240347/en/
Arthur D. Little's new report outlines a roadmap for embedding AI in development and engineering. (Photo: Business Wire)
The in-depth, comprehensive study, carried out with NAE (Netherlands Academy of Engineering), IVA (Royal Swedish Academy of Engineering Sciences), and KIVI (Koninklijk Instutuut van Ingenieurs), is based on information from over 900 AI and technology case studies, multiple hands-on projects, and survey feedback from 95 respondents across industries including high-tech, manufacturing, processing, pharmaceuticals and healthcare, defense, energy, and logistics.
Driven by changing customer demands that increase complexity, stricter regulatory requirements, and a fundamental shift from products to heterogenous solutions built on diverse technological domains, development and engineering must transform. Doing nothing is not an option.
AI is central to addressing these challenges, and the study has captured and curated a highly mature ecosystem of over 3,500 solution providers. This unique database helps show the complete field of possibilities for development and engineering teams. However, to maximize impact, AI tools must be deployed in conjunction with new ways of working – adopting a people-centric approach is vital. This requires organizations to develop capabilities, encourage appropriate mindsets, and enhance trust in AI’s reliability, explainability, and security.
The report outlines actionable recommendations, including a roadmap for embedding AI in development and engineering. This starts by building a balanced portfolio of AI applications, which should then be actioned using the Networked Lab of the Future, a four-step transformation approach. This includes empowering people through the adoption of AI (democratization) and leveraging internal and external data (data collaboration) to drive success.
Michaël Kolk, Managing Partner and Global Innovation Practice Leader at Arthur D. Little, comments: “Development and engineering is transforming, requiring new ways of working and new skills and capabilities. AI underpins this. While many high level reports outline AI’s theoretical potential, our study goes further, providing tangible actions that organizations can take now to realize the benefits of AI integration.”
Download the report here: https://tinyurl.com/5a52ed8c
View source version on businesswire.com: https://www.businesswire.com/news/home/20250219240347/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
IAS Launches IAS Total TV Solutions Giving Marketers ‘Linear-like’ Transparency for Connected TV27.4.2026 14:30:00 CEST | Press release
‘IAS Total TV’ unlocks show, genre and rating transparency measurement across Disney, NBCUniversal, Paramount and Prime Video, plus multiple opted-in publishers using Publica enabling advertisers to enhance brand suitability while increasing campaign outcomes Integral Ad Science (IAS) today announced ‘IAS Total TV’, a new comprehensive suite of Connected TV (CTV) solutions designed specifically to bring ‘linear-like’ transparency to streaming TV. IAS Total TV can provide marketers with genre, rating, language, show and program-level data in aggregate from Disney, NBCUniversal, Paramount and Prime Video, in addition to multiple opted-in publishers using Publica. IAS Total TV integrates content insights, media quality, supply path and outcomes into a unified view within the IAS Signal user interface (UI). Advertisers can determine when and how they want their advertising to run alongside CTV content, ensuring brand-related and brand suitable environments. “As advertisers continue to doub
Riskified Study Finds Consumers Aren’t Ready to Hand Over Control as AI Transforms Shopping, with Over Half Afraid of Online Fraud27.4.2026 14:00:00 CEST | Press release
New Q1 2026 “Agentic Commerce Pulse” survey from Riskified reveals a growing trust gap in agent-driven commerce, as consumers embrace AI across the shopping journey but remain hesitant to hand over control amid concerns over fraud, security, and accountability Riskified (NYSE: RSKD), a global leader in ecommerce fraud and risk intelligence, today released the Q1 2026 edition of its Agentic Commerce Pulse, a quarterly research series tracking agentic commerce risks and consumer engagement. Following Riskified’s inaugural Q4 2025 survey, which first highlighted the rapid emergence of agent-driven commerce, the latest findings reveal a more complex reality: while AI adoption remains strong, consumer trust is not keeping pace. A widening gap is emerging between how shoppers use AI and how much control they are willing to give it. The survey, conducted among consumers across the United States and the United Kingdom, shows that AI is now firmly embedded in product discovery and decision-maki
Nine in 10 Expect Cross-Border M&A Surge, But 71% of Dealmakers Have Already Changed Course on Deals27.4.2026 14:00:00 CEST | Press release
90% of dealmakers expect cross-border M&A activity to increase over the next 12–24 months75% cite foreign direct investment screening as the biggest threat to deal completion88% report longer signing-to-close timelines than three years ago Cross-border M&A is set for a strong resurgence, with nine in 10 senior dealmakers expecting activity to increase over the next 12 to 24 months, according to new research from CSC, the leading provider of business administration and compliance solutions. However, despite this renewed momentum, execution risk is rising, with regulatory scrutiny and operational challenges making it harder to get deals over the line. CSC¹ surveyed 200 director level and above global dealmakers across private equity, corporate, legal, and advisory roles who have worked on cross-border transactions in the past two years. The report, The New Reality of Cross-Border M&A: More Deals, More Friction, explores how firms are navigating an increasingly complex global deal environ
Mundipharma announces positive topline results from Phase III ReSPECT trial assessing ▼REZZAYO® (rezafungin) for the prophylaxis of invasive fungal diseases in allogeneic haematopoietic stem cell transplantation patients27.4.2026 13:43:00 CEST | Press release
For Trade and Medical Media Only The study primary endpoint was met, showing non-inferiority vs. standard antimicrobial regimen in fungal-free survival at Day 90 Study showed favourable benefit for toxicity-related discontinuations and drug-drug interactions (DDIs) Rezafungin was well tolerated, with a safety profile comparable to standard antimicrobial regimens (SARs) Mundipharma today announced positive Phase III topline results from the global ReSPECT clinical trial evaluating REZZAYO® (rezafungin acetate) for prophylaxis of invasive fungal diseases (IFDs) in adult patients undergoing allogeneic haematopoietic stem cell transplantation (HSCT). The ReSPECT Phase III trial, one of the largest antifungal, multicentre, randomised, double-blind studies evaluated the efficacy and safety of once weekly rezafungin compared with a SAR for the prophylaxis of IFDs, including infections caused by Candida, Aspergillus, and Pneumocystis, in adults undergoing allogeneic HSCT. Patients undergoing a
vVARDIS Announces Investment from Apollo—Achieves Unicorn Status27.4.2026 13:00:00 CEST | Press release
Investment will support global commercial expansion of the Curodont™ technology platform, the first and only non-invasive peptide-containing formulations designed to treat tooth decay drill-free throughout the depth of the lesion vVARDIS Holding AG (“vVARDIS”), a high-growth dental medtech company pioneering non-invasive cavity treatment, today announced a strategic minority investment from Apollo-managed funds (“Apollo Funds”). The investment will support vVARDIS’ next phase of global growth and commercial expansion, including the continued rollout of its Curodont™ suite of products. The investment establishes vVARDIS as one of Europe’s few privately owned, billion-dollar-plus, healthcare companies. vVARDIS’ founders and co-CEOs, Drs. Haley and Goly Abivardi, will retain a substantial majority shareholding in the company. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260415938477/en/ Photo credit: Jos Schmid, Photographer
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom